Targeting Tumor via Novel Drug Delivery System
Concanavalin-A conjugated Solid Lipid Nanoparticles bearing Mitoxantrone for Tumor Targeting
Nanotechnology will serve as multifunctional tools that will not only be used with any number of diagnostic and therapeutic agents, but will change the very foundations of cancer diagnosis,treatment, and prevention. Cancer is a genetically rooted disease that involves the simultaneous occurrence of two general categories of cellular malfunctions. Ligand-mediated targeting of anticancer therapeutics is being explored utilizing he potential of Nanotechnology. The basic principle underlies ligand-targeted therapeutics is that the delivery of antineoplastic drugs to cancer cells- or cancer-associated tissues such as tumor vasculature can be sel…
Mehr
CHF 66.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V105:
Folgt in ca. 15 Arbeitstagen
Produktdetails
Weitere Autoren: Jain, S. K. / Prajapati, S. K.
- ISBN: 978-3-8465-0949-4
- EAN: 9783846509494
- Produktnummer: 37771878
- Verlag: LAP Lambert Academic Publishing
- Sprache: Englisch
- Erscheinungsjahr: 2012
- Seitenangabe: 100 S.
- Masse: H22.0 cm x B15.0 cm x D0.6 cm 167 g
- Abbildungen: Paperback
- Gewicht: 167
Über den Autor
Alok Mahor joined Academics in 2008 & is working as an Assistant Professor in Institute of Pharmacy, Bundelkhand University, Jhansi, UP., India. He is Editor in Chief in International Journal of Pharmaceutical Sciences and Research & is also a member of various Professional Organizations. He has published various research papers in repute Journals.
Bewertungen
Anmelden